Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator Synergy Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia
We are Humbled by Our Talented Board and Employees!
Our responsibility to advance Diversity, Equity, and Inclusion is driven by a passionate belief that diverse thinking, skills, and experience bring the best outcome to our work as we innovate products and therapies that improve patients’ lives.
Interested in learning the impact of surgical LAA exclusion in non-Afib patients from a real-world data set? Join Dr. Patrick McCarthy at #AATS24 on Sunday, April 28, for the Presidential Recognition abstract.
#Cardiotwitter#LAAE#MedEd
Interested in learning the impact of surgical LAA exclusion in non-Afib patients from a real-world data set? Join Dr. Patrick McCarthy at #AATS24 on Sunday, April 28, for the Presidential Recognition abstract.
#Cardiotwitter#LAAE#MedEd
Discover Cryo Nerve Block at #AATS2024! Join us Saturday, 7 p.m., to explore its role in post-op pain management for thoracic procedures. Learn about its mechanism, patient referrals, and expectations, plus engage in a round table on professional experiences. Secure your spot:… https://t.co/pA0no3yqUU
Discover Cryo Nerve Block at #AATS2024! Join us Saturday, 7 p.m., to explore its role in post-op pain management for thoracic procedures. Learn about its mechanism, patient referrals, and expectations, plus engage in a round table on professional experiences. Secure your spot:… https://t.co/pA0no3yqUU
Cardiothoracic surgeon Dr. Drotar and EP Dr. Atteya from @CBMCNJ joined forces to treat their first LSPAF patient with Hybrid AF™ Therapy.
Together, they exemplify a dual approach yielding better outcomes. Discover the innovative strategy reshaping LSPAF treatment:… https://t.co/G2e1DJu6CB
Cardiothoracic surgeon Dr. Drotar and EP Dr. Atteya from @CBMCNJ joined forces to treat their first LSPAF patient with Hybrid AF™ Therapy.
Together, they exemplify a dual approach yielding better outcomes. Discover the innovative strategy reshaping LSPAF treatment:… https://t.co/G2e1DJu6CB
Our passion for helping others extends into our communities through our employees’ drive and commitment to giving back.
From working with organizations like the American Heart Association, local non-profits and food drives, we provide two days of Volunteer Time Off each year to employees to support local causes.
#ThisIsAtriCure#NationalVolunteerWeek
Our passion for helping others extends into our communities through our employees’ drive and commitment to giving back.
From working with organizations like the American Heart Association, local non-profits and food drives, we provide two days of Volunteer Time Off each year to employees to support local causes.
#ThisIsAtriCure#NationalVolunteerWeek
What is a sinus node sparing hybrid ablation? It...
- Is a minimally invasive procedure
- Offers direct visualization of key heart structures
- Can reduce damage to adjacent tissues like the esophagus or phrenic nerve
- Allows for sinus node identification via endocardial mapping and precise epicardial ablation
Learn more about this new procedure being evaluated in the HEAL-IST clinical trial at www.heal-ist.com.
What is a sinus node sparing hybrid ablation? It...
- Is a minimally invasive procedure
- Offers direct visualization of key heart structures
- Can reduce damage to adjacent tissues like the esophagus or phrenic nerve
- Allows for sinus node identification via endocardial mapping and precise epicardial ablation
Learn more about this new procedure being evaluated in the HEAL-IST clinical trial at www.heal-ist.com.
Pectus patients and families face tough decisions regarding the Nuss procedure's post-op pain and recovery process. With Cryo Nerve Block, we're reshaping the conversation.
Discover why Dr. Mark Walton integrated #CryoNB into his practice and learn how it’s putting patients like Brandon at ease:
https://okt.to/LilmNO
Hamilton Health Sciences
Pectus patients and families face tough decisions regarding the Nuss procedure's post-op pain and recovery process. With Cryo Nerve Block, we're reshaping the conversation.
Discover why Dr. Mark Walton integrated #CryoNB into his practice and learn how it’s putting patients like Brandon at ease:
https://okt.to/LilmNO
Hamilton Health Sciences
We’ve reached a milestone in our LeAAPS™ Trial – more than 2,000 patients are now enrolled! As the largest randomized clinical trial in cardiac surgery history, the trial is set to evaluate whether LAA exclusion can reduce stroke in cardiac surgery patients with no prior history of Afib.
Want to learn more about the groundbreaking study? Visit: https://okt.to/viYPjO
#ClinicalTrial#Stroke
We’ve reached a milestone in our LeAAPS™ Trial – more than 2,000 patients are now enrolled! As the largest randomized clinical trial in cardiac surgery history, the trial is set to evaluate whether LAA exclusion can reduce stroke in cardiac surgery patients with no prior history of Afib.
Want to learn more about the groundbreaking study? Visit: https://okt.to/viYPjO
#ClinicalTrial#Stroke
Congratulations to Barts Heart Centre - Barts Health NHS Trust, St George's University Hospitals NHS Foundation Trust, and Bristol Heart Institute - University Hospitals Bristol and Weston NHS Foundation Trust for leading the first UK cases with EPi-Sense ST™ Device! EPi-Sense ST offers a new approach to ablation procedures, allowing surgeons to fine-tune their technique using deflection and braided catheter design for precise coil placement, while an intuitive handle design facilitates controlled positioning.
Thanks to Drs. John Jap, Syed Ahsan, Aziz Momin, Riyaz Kaba, Cha Rajakaruna, and Ashley Nisbet along with their exceptional teams, for providing this treatment to their patients!
Discover more: https://bit.ly/3UBFFna
#HybridAFTherapy#Afib
Congratulations to Barts Heart Centre - Barts Health NHS Trust, St George's University Hospitals NHS Foundation Trust, and Bristol Heart Institute - University Hospitals Bristol and Weston NHS Foundation Trust for leading the first UK cases with EPi-Sense ST™ Device! EPi-Sense ST offers a new approach to ablation procedures, allowing surgeons to fine-tune their technique using deflection and braided catheter design for precise coil placement, while an intuitive handle design facilitates controlled positioning.
Thanks to Drs. John Jap, Syed Ahsan, Aziz Momin, Riyaz Kaba, Cha Rajakaruna, and Ashley Nisbet along with their exceptional teams, for providing this treatment to their patients!
Discover more: https://bit.ly/3UBFFna
#HybridAFTherapy#Afib
Over the next five years, the LeAAPS™ Trial will monitor 6,500 cardiac surgery participants, half of which will receive an AtriClip® device but have had no prior history of Afib.
The study will assess whether LAAE using AtriClip devices can reduce stroke risk in cardiac surgery patients without a history of Afib.
To learn more about the study and participant qualifications, visit: https://okt.to/KBvuMr#Clinicalstudy#stroke#AtriClip
Over the next five years, the LeAAPS™ Trial will monitor 6,500 cardiac surgery participants, half of which will receive an AtriClip® device but have had no prior history of Afib.
The study will assess whether LAAE using AtriClip devices can reduce stroke risk in cardiac surgery patients without a history of Afib.
To learn more about the study and participant qualifications, visit: https://okt.to/KBvuMr#Clinicalstudy#stroke#AtriClip
The EPi-Sense ST™ Device is now MDR approved and available across Europe for the treatment of Advanced Afib patients. The first European cases took place at Asklepios Klinikum Harburg, Deutsches Herzzentrum der Charité (DHZC), Centro Cardiologico Monzino, Rigshospitalet and Institut Mutualiste Montsouris.
EPi-Sense ST offers increased deflection and a catheter braided design to provide greater control in the positioning of the device.
Learn more about EPi-Sense ST: https://lnkd.in/gt-iHpMD
Thank you to Drs. Prof. Dr. Thorsten Hanke and Vladimir Vulević, Prof. Dr. Christoph Starck, Claudio Tondo, Eleonora Penza, Giulia Vettor and Gianluca Polvani, Christian Lildal Carranza, and IMM’s Cardiac Department and their teams for offering this treatment option to their patients!
#HybridAFTherapy#Epeeps#Cardiac#CardiacSurgery
The EPi-Sense ST™ Device is now MDR approved and available across Europe for the treatment of Advanced Afib patients. The first European cases took place at Asklepios Klinikum Harburg, Deutsches Herzzentrum der Charité (DHZC), Centro Cardiologico Monzino, Rigshospitalet and Institut Mutualiste Montsouris.
EPi-Sense ST offers increased deflection and a catheter braided design to provide greater control in the positioning of the device.
Learn more about EPi-Sense ST: https://lnkd.in/gt-iHpMD
Thank you to Drs. Prof. Dr. Thorsten Hanke and Vladimir Vulević, Prof. Dr. Christoph Starck, Claudio Tondo, Eleonora Penza, Giulia Vettor and Gianluca Polvani, Christian Lildal Carranza, and IMM’s Cardiac Department and their teams for offering this treatment option to their patients!
#HybridAFTherapy#Epeeps#Cardiac#CardiacSurgery
Interested in learning the impact of surgical LAA exclusion in non-Afib patients from a real-world data set? Join Dr. Patrick McCarthy at #AATS24 on Sunday, April 28, for the Presidential Recognition abstract.
#Cardiac#LAAE#MedEd
Interested in learning the impact of surgical LAA exclusion in non-Afib patients from a real-world data set? Join Dr. Patrick McCarthy at #AATS24 on Sunday, April 28, for the Presidential Recognition abstract.
#Cardiac#LAAE#MedEd
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
social media channels to keep updated on the latest at AtriCure.
Blake's Pectus Excavatum Journey: 2 Months Post-Op
Duration: 2:31
Blake's Pectus Excavatum Journey: Surgery
Duration: 2:49
Blake's Pectus Excavatum Journey: 1 Week Pre-Op
Duration: 3:41
Blake's Pectus Excavatum Journey: 1 Month Pre-Op
Duration: 2:58